Serologic markers of hepatitis - B infection in bronchial asthma

Raghunanthan, T and Deepak, Arjundas and Sivakumar, M R and Nalini, Krishnan and Basheer, Ahmed and Thiruvengadam, K V and Kumaraswami, V and Suniti, Solomon and Thiyagarajan, S P (1984) Serologic markers of hepatitis - B infection in bronchial asthma. Lung India, 2 (2). pp. 192-194. ISSN Print: 0970-2113; Online: 0974-598X

Preview

PDF 198410.pdf - Published Version Download (252kB)

Abstract

Subjected to frequent parenteral drug and allergen administration, patients with bronchial asthma are likely to be at risk of contracting hepatitis B infection. In addition, those receiving immunotherapy are subjected to more frequent parenteral medication and hence are at a greater risk than those on only pharmacologic therapy. This problem was studied among 60 patients with bronchial asthma – 30 on immunotherapy and 30 on pharmacotherapy. A higher prevalence of Hepatitis B surface antigen (HBs Ag) among patients with bronchial asthma than in the general population was detected but no difference was found between the two groups.

Item Type:	Article
URI:	http://eprints.nirt.res.in/id/eprint/175

Actions (login required)

View Item